Satoru Miura

机构：Niigata Cancer Center Hospital · ORCID：0000-0001-7868-6661

发表论文 292 篇 · 总被引 3608 次 · h-index 31

代表论文

• Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834 (2025 · Journal of Clinical Oncology · 被引 33)
• A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non‐Small Cell Lung Cancer (NEXTAC‐TWO) (2025 · Journal of Cachexia Sarcopenia and Muscle · 被引 12)
• Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learning (2025 · Lung Cancer · 被引 5)
• Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study (2024 · Lung Cancer · 被引 5)
• Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529) (2025 · Radiation Oncology · 被引 4)
• Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer (2024 · Lung Cancer · 被引 4)